JPRN-UMIN000003617已完成未知
A study of safety and efficacy of R410 for acne vulgaris. - A study of safety and efficacy of R410 for acne vulgaris.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Subjects with clinically-significant disorder that might influence the outcome of this study. 2.Acne conglobata, acne fulminans, or secondary acne (e.g. chloracne, drug-induced acne). 3.Subjects for whom the systemic treatment of acne vulgaris is necessary. 4.Underlying diseases or skin symptoms (e.g. atopic dermatitis, perioral dermatitis, rosacea), with topical or systemic treatment which could interfere with the study assesment. 5.History of hypersensitivity to any components of the study preparations. 6.Change in the use of facial cleanser or skin care products for acne within the past 1 month. 7.Use of the following items within the specified washout period or during the study. 7.1 Topical preparations and therapy applied to the sites to be studied 1)Topical preparations i)Use of the following preparations within the past 4 weeks. -Retinoids ii)Use of the following preparations within the past 2 weeks. -Benzoyl Peroxide -Corticosteroids -Exfoliating products including hydroxy acids, except facial cleanser 2)Therapy etc. i)Chemical peels, laser treatment, photo therapy, esthetic treatment, surgery of face. 7.2 Systemic drugs 1)Use of the following preparations within the past 12 weeks. -Retinoids 2)Use of the following preparations within the past 4 weeks. -Other acne treatments including antimicrobials etc. (except vitamin and cystein preparations) -Corticosteroids -Hormone preparations -Kampo preparations likely to be effective for acne 8.Subjects who are improper to entry this study, with some complications, e.g. severe heart disease, renal disorder, hepatic disorder, respiratory disease, cardiovascular disease, immune disorder. 9.Female who is pregnant, trying to become pregnant (self- declared), during this study period, or breast feeding. 10.Participation in another clinical study within the past 3 months. 11.Subjects who are improper as the participant in the study in judgement of the principal or the other investigators.
研究者
相似试验
进行中（未招募）
不适用
An assessment of the safety and efficacy of the Acne Scar Treatment Pen to treat facial acne scarsISRCTN18051758Medical Brands B.V.66
已完成
2 期
Clinical study on Anti-acne face pack in pimplesCTRI/2022/07/044012amaskar Ayurved Private Limited32
已完成
2 期
Clinical study on Anti-acne spot oil in pimplesCTRI/2022/07/044013amaskar Ayurved Private Limited30
进行中（未招募）
1 期
ot applicableAcne vulgarisMedDRA version: 19.0Level: LLTClassification code 10000519Term: Acne vulgarisSystem Organ Class: 100000004858EUCTR2016-000063-16-DEGalderma R&D SNC60
已完成
不适用
Efficacy of Acne Recovery LotioCTRI/2021/10/037356IKKOL GROUP COSMOS TECHNICAL CENTER CO LTD30